Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

17 Republicans rebel against House GOP leaders, join Dems to pass Obamacare extension

by admin January 9, 2026
January 9, 2026
17 Republicans rebel against House GOP leaders, join Dems to pass Obamacare extension

The House of Representatives passed a bill to revive and extend COVID-19 pandemic-era enhanced Obamacare subsidies in a major victory for Minority Leader Hakeem Jeffries, D-N.Y.

Seventeen House Republicans broke ranks with GOP leaders to support the legislation after Democrats were successful in forcing a vote via a mechanism called a privileged resolution. The bill passed 230-196.

A discharge petition is a mechanism for getting legislation considered on the House floor even if the majority’s leadership is opposed to it, provided the petition gets a majority of House lawmakers’ signatures.

Jeffries filed a discharge petition late last year, which was then signed by four House Republicans — helping it clinch the critical majority threshold.

Five more House Republicans joined Democrats in a vote Wednesday evening to advance the legislation for final consideration Thursday.

The 17 Republicans who voted for the legislation were Reps. Brian Fitzpatrick, R-Pa.; Mike Lawler, R-N.Y.; Rob Bresnahan, R-Pa.; Ryan Mackenzie, R-Pa.; Mike Carey, R-Ohio; Monica De La Cruz, R-Texas; Andrew Garbarino, R-N.Y.; Will Hurd, R-Colo.; Dave Joyce, R-Ohio; Tom Kean Jr., R-N.J., Nick LaLota, R-N.Y., Max Miller, R-Ohio; Zach Nunn, R-Iowa; Maria Salazar, R-Fla.; Dave Valadao, R-Calif.; Derrick Van Orden, R-Wis.; and Rob Wittman, R-Va.

It underscores the perilously slim margins Speaker Mike Johnson, R-La., is governing with.

House Republicans hold just a two-vote majority with full attendance on both sides, numbers that could easily shift when lawmakers are absent for personal or health reasons.

As Rep. Tim Burchett, R-Tenn., put to reporters on Wednesday morning, ‘We are one flu season away from losing the majority.’

The successful vote on Thursday is a blow for Johnson, who argued for weeks that the majority of House Republicans were opposed to extending the COVID-19 pandemic-era tax subsidies.

But a significant number of GOP moderates were frustrated that their party leaders in the House and Senate had done little to avert a price hike for millions of Americans’ insurance premiums. 

A Democrat-controlled Congress voted twice, in 2020 and in 2021, to enhance Obamacare subsidies to give more people access to federal healthcare during the pandemic.

Those subsidies were only extended through 2025, however.

The vast majority of Republicans believe the subsidies are a COVID-era relic of a long-broken federal healthcare system. Conservatives argued that the relatively small percentage of Americans who rely on Obamacare meant that an extension would do little to ease rising health costs that people across the country are experiencing.

But a core group of moderates has been arguing that a failure to extend a reformed version of them would force millions of Americans to grapple with skyrocketing healthcare costs this year.

Those moderates were also frustrated with Jeffries for not working with Republicans on a bipartisan solution to the subsidies but felt they were left with little choice but to support Democrats’ bid in the end.

House Republicans passed a healthcare bill in mid-December aimed at lowering those costs for a broader swath of Americans, but that legislation has not been taken up in the Senate.

There’s also little chance the three-year extension will pass the upper chamber, however. Similar legislation led by Senate Democrats failed to reach the necessary 60-vote threshold to advance in December.

This post appeared first on FOX NEWS

previous post
Trump plans to meet with Venezuela opposition leader Maria Corina Machado next week
next post
European allies working on plan if US acts on acquiring Greenland: report

related articles

New book reveals what Kamala Harris ‘moaned’ to...

September 24, 2025

Iran still wants a nuclear weapon despite ‘serious...

July 6, 2025

Canada stares down consequences of Trump tariff war:...

April 2, 2025

His brothers’ keeper: Liran Berman calls for urgent...

March 27, 2025

Key Trump agency facing ‘unprecedented backlog’ inherited from...

April 15, 2025

Congress unveils spending plan after Trump calls on...

March 9, 2025

Hawley rips Jack Smith’s ‘Biden’s Stasi’ probe, calls...

October 7, 2025

JONATHAN TURLEY: Justice Jackson plays pundit to dismay...

July 12, 2025

Trump reveals which major US city is next...

October 16, 2025

Fetterman hospitalized after fall near home in Pennsylvania

November 14, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (3,290)
    • Latest News (2,300)
    • Politics (3,969)
    • Stocks (1,188)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved